Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report
- Abstract
- The incidence of large cell neuroendocrine carcinoma (LCNEC) of the lung is rare, and the treatment methods and prognosis for such patients are still subjects of debate. We report a case of a 78-year-old male LCNEC patient for whom stereotactic body radiation therapy was performed. A four-dimensional computed tomography scan was used for simulation, and radiotherapy was planned using the volumetrically modulated arc technique. A total of 55 Gy was delivered in five daily fractions. The treatment was safely completed, and the patient did not report any discomfort. The only side-effect was an intermittent cough. Currently, the patient has received 18 months of outpatient follow-up care with no evidence of disease. In conclusion, stereotactic body radiation therapy can be a valuable treatment option for early stage LCNEC.
- All Author(s)
- I. Y. Jo
; S. G. Yeo
- Intsitutional Author(s)
- 조인영
- Issued Date
- 2019
- Type
- Article
- Keyword
- large cell; lung; neuroendocrine carcinoma; radiation therapy; stereotactic ablative radiotherapy
- Publisher
- Dove Medical Press
- ISSN
- 1178-6930
- Citation Title
- OncoTargets and therapy
- Citation Volume
- 12
- Citation Start Page
- 1359
- Citation End Page
- 1364
- Language(ISO)
- eng
- DOI
- 10.2147/ott.S189858
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/2548
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.